Koa Shoji Holdings Co.,Ltd.

Equities

9273

JP3283420002

Commodity Chemicals

Delayed Japan Exchange 02:00:00 2024-05-02 am EDT 5-day change 1st Jan Change
842 JPY +0.48% Intraday chart for Koa Shoji Holdings Co.,Ltd. +3.57% +15.03%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Koa Shoji Holdings Co.,Ltd. Provides Dividend Guidance for the Fiscal Year Ending June 30, 2024 CI
Koa Shoji Holdings Co.,Ltd. Provides Dividend Guidance for the Year Ending June 30, 2024 CI
Koa Shoji Holdings Co.,Ltd. Provides Consolidated Earnings Guidance for Year Ending June 30, 2024 CI
Koa Shoji Holdings Co.,Ltd. Provides Consolidated Earnings Guidance for Year Ending June 30, 2023 CI
Koa Shoji Holdings Co.,Ltd. Reports Earnings Results for the Nine Months Ended March 31, 2023 CI
Koa Shoji Holdings Co.,Ltd. Provides Consolidated Earnings Guidance for the Year Ending June 30, 2023 CI
Koa Shoji Holdings Co.,Ltd. Provides Dividend Guidance for the Year Ending June 30, 2023 CI
Koa Shoji's Attributable Profit Flat in Fiscal Q1 MT
Koa Shoji Holdings Co.,Ltd. Provides Dividend Guidance for the Year Ending June 30, 2023 CI
Koa Shoji Holdings Co.,Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending June 30, 2023 CI
Haze Shoji Co., Ltd. cancelled the acquisition of 40% stake in Koa Shoji Holdings Co.,Ltd. from Toshiyuki Shudo. CI
Haze Shoji Co., Ltd. agreed to acquire 40% stake in Koa Shoji Holdings Co.,Ltd. from Toshiyuki Shudo. CI
Certain Common Stock of Koa Shoji Holdings Co.,Ltd. are subject to a Lock-Up Agreement Ending on 17-DEC-2018. CI
Koa Shoji Holdings Co.,Ltd. has completed an IPO in the amount of ¥986.832 million. CI
Koa Shoji Holdings Co.,Ltd. has filed an IPO. CI
Chart Koa Shoji Holdings Co.,Ltd.
More charts
KOA SHOJI HOLDINGS CO., LTD. is engaged in purchasing and sales of drug substance, manufacturing, purchasing and sales of pharmaceuticals, including medical prescription drugs and general pharmaceutical products, as well as contract manufacturing of formulation of pharmaceuticals. The Company operates through two business segments. The pharmaceutical manufacturing and sales business is engaged in development, manufacturing, contract manufacturing and sales of generic injection, oral preparation and external preparation. The drug substance sales business is engaged in import and export of generic drug raw materials, as well as introducing and supply of pharmaceutical raw materials and preparations.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
842 JPY
Average target price
1,500 JPY
Spread / Average Target
+78.15%
Consensus
  1. Stock Market
  2. Equities
  3. 9273 Stock
  4. News Koa Shoji Holdings Co.,Ltd.
  5. Koa Shoji's Attributable Profit Flat in Fiscal Q1